Rosacea Blepharoconjunctivitis Treated with a Novel Preparation of Dilute Povidone Iodine and Dimethylsulfoxide: a Case Report and Review of the Literature

被引:9
作者
Pelletier J.S. [1 ,2 ]
Stewart K.P. [1 ,3 ]
Capriotti K. [1 ,4 ]
Capriotti J.A. [1 ,3 ]
机构
[1] ALC Therapeutics, LLC, Springhouse, PA
[2] Ocean Ophthalmology Group, Miami, FL
[3] Plessen Ophthalmology Consultants, Christiansted, VI
[4] Bryn Mawr Skin and Cancer Institute, Rosemont, PA
关键词
Blepharitis; Conjunctivitis; Dimethylsulfoxide; Povidone iodine; Rosacea;
D O I
10.1007/s40123-015-0040-4
中图分类号
学科分类号
摘要
Introduction: Povidone iodine (PVP-I) 10% aqueous solution is a commonly utilized anti-septic employed for sterilization of the ocular surface prior to interventional procedures. Dimethylsulfoxide (DMSO) is a well-known skin penetration agent scarcely utilized in ophthalmic drug formulations. We describe here a low-dose formulation of 1% PVP-I (w/w) in a gel containing DMSO for use in the setting of recalcitrant rosacea blepharoconjunctivitis. A review of the ocular uses of dimethylsulfoxide is also presented. Case report: A 78-year-old male presented with chronic, long-standing blepharitis involving both the anterior and posterior lid margins. Posterior lid and skin inflammatory changes were consistent with ocular rosacea. Previous oral and topical therapies had been largely ineffective at controlling his condition. Conclusion: The topical PVP-I/DMSO system was effective in abating the signs and symptoms of rosacea blepharoconjunctivitis. Further investigation of this novel agent is warranted. © 2015, The Author(s).
引用
收藏
页码:143 / 150
页数:7
相关论文
共 40 条
[1]  
Lemp M.A., Nichols K.K., Blepharitis in the United States 2009: a survey-based perspective on prevalence and treatment, Ocul Surf., 7, pp. S1-S14, (2009)
[2]  
Pflugfelder S.C., Karpecki P.M., Perez V.L., Treatment of blepharitis: recent clinical trials, Ocul Surf., 12, 4, pp. 273-284, (2014)
[3]  
Mathers W., cluster analysis of patients with ocular surface disease, blepharitis, and dry eye., Arch Ophthalmol, 112, 11, pp. 4-1700
[4]  
Preferred practice patterns: blepharitis., (2008)
[5]  
Two A.M., Wu W., Gallo R.L., Hata T.R., Rosacea: part I. Introduction, categorization, histology, pathogenesis, and risk factors, J Am Acad Dermatol., 72, 5, pp. 749-758, (2015)
[6]  
Duncan K., Jeng B.H., Medical management of blepharitis, Curr Opin Ophthalmol, 26, 4, pp. 289-294, (2015)
[7]  
Mcculley J.P., Shine W.E., Meibomian gland function and the tear lipid layer, Ocul Surf., 1, 3, pp. 97-106, (2003)
[8]  
Oshima Y., Sato H., Zaghloul A., Foulks G.N., Yappert M.C., Borchman D., Characterization of human meibum lipid using raman spectroscopy, Curr Eye Res, 34, 10, pp. 824-835, (2009)
[9]  
O'brien T.P., The role of bacteria in blepharitis, Ocul Surf, 7, pp. S21-S22, (2009)
[10]  
Dougherty J.M., Mcculley J.P., Comparative bacteriology of chronic blepharitis, Br J Ophthalmol, 68, 8, pp. 524-528, (1984)